DocSym
β
Searchsearch
Search
(C96.7) Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
More details coming soon
123 676 in individuals diagnosis other specified malignant neoplasms of lymphoid, haematopoietic and related tissue confirmed
37 151 deaths with diagnosis other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
30% mortality rate associated with the disease other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
Diagnosis other specified malignant neoplasms of lymphoid, haematopoietic and related tissue is diagnosed Men are 17.09% more likely than Women
72 407
Men receive the diagnosis other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
17 751 (24.5 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
51 269
Women receive the diagnosis other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
19 400 (37.8 %)Died from this diagnosis.
Risk Group for the Disease other specified malignant neoplasms of lymphoid, haematopoietic and related tissue - Men aged 75-79 and Women aged 70-74
In Men diagnosis is most often set at age 0-94
Less common in men the disease occurs at Age 95+in in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
Absence or low individual and public risk
Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue - what does this mean
Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue occur when cells in the blood, bone marrow, and lymphatic system grow and divide uncontrollably. this growth can form tumors, which can spread to other parts of the body.
What happens during the disease - other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
The pathogenesis of other specified malignant neoplasms of lymphoid, haematopoietic and related tissue is believed to be caused by mutations in the dna of the lymphoid, haematopoietic, and related tissue cells. these mutations can cause the cells to divide and grow uncontrollably, leading to the formation of malignant tumors. in some cases, these mutations can be inherited, while in others they can be caused by environmental factors such as radiation or certain chemicals.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete physical examination
- Complete blood count
- Blood chemistry tests
- Bone marrow biopsy
- Imaging tests (X-ray, CT, MRI, PET scan)
- Lymph node biopsy
- Lymph node aspiration
- Flow cytometry
- Cytogenetic tests
- Molecular genetic tests
Treatment and Medical Assistance
Main Goal of Treatment: To reduce the size of the tumor and to prevent the spread of cancer to other parts of the body.
- Surgery to remove the tumor and affected lymph nodes
- Chemotherapy to destroy cancer cells
- Radiation therapy to shrink the tumor
- Stem cell transplant to replace damaged cells
- Immunotherapy to boost the immune system
- Targeted therapy to attack specific cancer cells
16 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue - Prevention
The best way to prevent other specified malignant neoplasms of lymphoid, haematopoietic and related tissue is to reduce risk factors such as smoking, alcohol consumption, and exposure to certain chemicals and radiation. additionally, maintaining a healthy lifestyle, including a balanced diet and regular exercise, can help to reduce the risk of developing this type of cancer.